Popular Searches:

drugs

viagra

diet pills
drugs prescription drugs weight loss drugs drugs online discount drugs drugstore drugs for depression online drugstore online drugs canadian drugs cheap drugs nc drugs facilities fertility drugs canada drugs brands only drugs acyclovir adipex ambien antibiotic carisoprodol celebrex didrex diet pills discount xenical hydrocodone ionamin lortab meridia online soma paxil penis enlargement phentermine prevacid prilosec propecia prozac renova retin-a senior health soma sonata tenuate tramadol ultram valium valtrex vaniqa viagra vicodin vioxx vitamin wagering weight weight loss wellbutrin women health xanax xenical xenical online zocor zoloft zovirax zyban zyrtec
A1, A2, B, C1, C2, D, E, F, G-H, I-K, L, M, N, O, P1, P2, Q-R, S, T, U-V, W-Z

Darvocet-N Pharmacology, Pharmacokinetics, Studies, Metabolism - Propoxyphene Napsylate and Acetaminophen

Darvocet-N Pharmacology, Pharmacokinetics, Studies, Metabolism - Propoxyphene Napsylate and Acetaminophen

CLINICAL PHARMACOLOGY

Propoxyphene is a centrally acting narcotic analgesic agent. Equimolar doses of propoxyphene hydrochloride or napsylate provide similar plasma concentrations. Following administration of 65, 130, or 195 mg of propoxyphene hydrochloride, the bioavailability of propoxyphene is equivalent to that of 100, 200, or 300 mg respectively of propoxyphene napsylate. Peak plasma concentrations of propoxyphene are reached in 2 to 2 ½ hours. After a 100-mg oral dose of propoxyphene napsylate, peak plasma levels of 0.05 to 0.1 mcg/ml are achieved. The napsylate salt tends to be absorbed more slowly than the hydrochloride. At or near therapeutic doses, this absorption difference is small when compared with that among subjects and among doses (for graphic illustration please see manufacturer's original package insert).

Because of this several hundredfold difference in solubility, the absorption rate of very large doses of the napsylate salt is significantly lower than that of equimolar doses of the hydrochloride.

Repeated doses of propoxyphene at 6-hour intervals lead to increasing plasma concentrations with a plateau after the ninth dose at 48 hours.

Propoxyphene is metabolized in the liver to yield norpropoxyphene. Propoxyphene has a half-life of 6 to 12 hours, whereas that of norpropoxyphene is 30 to 36 hours.

Norpropoxyphene has substantially less central-nervous-system-depressant effect than propoxyphene but a greater local anesthetic effect, which is similar to that of amitriptyline and antiarrhythmic agents, such as lidocaine and quinidine.

In animal studies in which propoxyphene and norpropoxyphene were continuously infused in large amounts, intracardiac conduction time (PR and QRS intervals) was prolonged. Any intracardiac conduction delay attributable to high concentrations of norpropoxyphene may be of relatively long duration.

Propoxyphene is a mild narcotic analgesic structurally related to methadone. The potency of propoxyphene napsylate is from two thirds to equal that of codeine.

Propoxyphene napsylate and acetaminophen tablets provide the analgesic activity of propoxyphene napsylate and the antipyretic-analgesic activity of acetaminophen.

The combination of propoxyphene and acetaminophen produces greater analgesia than that produced by either propoxyphene or acetaminophen administered alone.

ANIMAL PHARMACOLOGY

Animal Toxicology: The acute lethal doses of the hydrochloride and napsylate salts of propoxyphene were determined in 4 species. The results shown in TABLE 1 indicate that on a molar basis the napsylate salt is less toxic than the hydrochloride. This may be due to the relative insolubility and retarded absorption of propoxyphene napsylate.

  TABLE 1 Acute Oral Toxicity Of Propoxyphene
  LD50 (mg/kg) ± SE
  LD50 (mmol/kg)

Species

Propoxyphene Hydrochloride Propoxyphene Napsylate
Mouse 282 ± 39 915 ± 163
  0.75 1.62
Rat 230 ± 44 647 ± 95
  0.61 1.14
Rabbit ca. 82 >183
  0.22 >0.32
Dog ca. 100 >183
  0.27 >0.32


Some indication of the relative insolubility and retarded absorption of propoxyphene napsylate was obtained by measuring plasma propoxyphene levels in 2 groups of 4 dogs following oral administration of equimolar doses of the 2 salts. The peak plasma concentration observed with propoxyphene hydrochloride was much higher than that obtained after administration of the napsylate salt.

Although none of the animals in this experiment died, 3 of the 4 dogs given propoxyphene hydrochloride exhibited convulsive seizures during the time interval corresponding to the peak plasma levels. The 4 animals receiving the napsylate salt were mildly ataxic but not acutely ill. (For graphic illustration please see manufacturer's original package insert).

top


Popular Searches:

weight loss

ultram

penis enlargement

hydrocodone

antibiotic